Europe Cosmetic Surgery Market Size Likely to Surpass at a CAGR of 10.2% By 2033

As per the current market research conducted by the CMI Team, the Europe Cosmetic Surgery Market size is expected to record a CAGR of 10.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 23,853.7 Million. By 2033, the valuation is anticipated to reach USD 57,172.8 Million.

Europe Cosmetic Surgery Market: Growth Factors and Dynamics

• Increasing Disposable Income: As disposable incomes rise in many European countries, more individuals can afford cosmetic procedures, leading to market growth. Higher disposable income often correlates with increased spending on personal aesthetics and self-care.

• Aging Population: Europe has a significant aging population, particularly in countries like Germany, Italy, and France. As people age, the demand for anti-aging procedures, such as facelifts, Botox, and dermal fillers, increases, driving the market.

• Technological Advancements: Innovations in cosmetic surgery techniques and non-invasive procedures have made these options safer, more effective, and with quicker recovery times. Advanced technologies, such as laser treatments and new implant materials, attract more patients to opt for cosmetic enhancements.

• Growing Acceptance and Social Influence: The stigma around cosmetic surgery has decreased over the years, with growing acceptance driven by social media influencers and celebrities openly discussing their procedures. This cultural shift encourages more people to consider cosmetic surgery as a viable option for enhancing their appearance.

• Medical Tourism: Several European countries, such as Turkey, Hungary, and Poland, have become popular destinations for medical tourism due to their high-quality medical services at competitive prices. Patients from other parts of Europe and beyond travel to these countries for affordable cosmetic procedures, boosting the local market.

• Regulatory Environment and Safety Standards: Europe has stringent regulations and high safety standards for medical procedures, including cosmetic surgery. This regulatory framework ensures patient safety and builds trust in the market, encouraging more individuals to undergo cosmetic procedures knowing they are in safe hands.

• Rising Awareness and Education: Increased awareness and education about the available cosmetic surgery options, their benefits, and potential risks have empowered consumers to make informed decisions. Information dissemination through online platforms, health campaigns, and consultations with medical professionals contributes to market growth.

• Expansion of Aesthetic Clinics and Spas: The proliferation of specialized aesthetic clinics and medical spas across Europe has made cosmetic procedures more accessible to a wider audience. These facilities often offer a range of both surgical and non-surgical treatments, providing consumers with convenient options for enhancing their appearance.

Europe Cosmetic Surgery Market: Partnership and Acquisitions

• In 2022, Cynosure expanded its partnership with Jeisys Medical through an agreement making Cynosure the exclusive global distributor of Jeisys’ Potenza Radio Frequency Micro-Needling System. This collaboration strengthens their market presence in advanced aesthetic treatments.

• In 2021, AbbVie Inc.’s acquisition of Allergan has expanded its market reach and product portfolio, bolstering future demand. The merger integrates diverse cosmetic and pharmaceutical offerings, enhancing AbbVie’s competitiveness and market positioning in the industry.

Report Scope

Europe Cosmetic Surgery Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Europe Cosmetic Surgery Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Temporary Shutdowns and Reduced Elective Procedures: During the height of the pandemic, many cosmetic surgery clinics and elective procedure departments in hospitals were temporarily shut down or operated at reduced capacity to comply with lockdowns and redirect medical resources towards treating COVID-19 patients. This led to a significant decline in the number of cosmetic procedures performed.

• Supply Chain Disruptions: The pandemic disrupted global supply chains, affecting the availability of medical supplies and equipment necessary for cosmetic procedures. This caused delays in procedures and impacted the overall efficiency of cosmetic surgery services.

• Resumption of Elective Procedures: As lockdowns eased and healthcare systems stabilized, elective procedures, including cosmetic surgeries, resumed. Clinics adapted to new safety protocols to ensure patient and staff safety, allowing for a gradual return to normal operations.

• Increased Focus on Self-Care and Aesthetics: The pandemic led to an increased focus on self-care and personal well-being. Many individuals, spending more time at home and on virtual platforms, became more conscious of their appearance, driving demand for cosmetic procedures once clinics reopened.

• Adoption of Telemedicine for Consultations: Telemedicine became a popular tool for initial consultations and follow-ups. This innovation allowed patients to discuss their options and plan procedures without the need for in-person visits, making the process more convenient and accessible.

• Enhanced Safety and Hygiene Protocols: Cosmetic surgery clinics implemented enhanced safety and hygiene protocols, such as rigorous sanitization, social distancing, and the use of personal protective equipment (PPE). These measures reassured patients about the safety of undergoing procedures during the ongoing pandemic.

• Flexible Financing Options: To attract and accommodate patients facing financial uncertainties due to the pandemic, many clinics offered flexible financing options and payment plans. This made cosmetic procedures more accessible to a broader range of individuals seeking aesthetic enhancements.

• Increased Marketing and Awareness Campaigns: Cosmetic surgery clinics ramped up their marketing efforts, utilizing social media, online platforms, and virtual consultations to reach potential clients. Increased awareness and targeted advertising helped clinics reconnect with existing patients and attract new ones.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Europe Cosmetic Surgery Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Europe Cosmetic Surgery Market:

• Allergan plc
• Galderma S.A.
• Mentor Worldwide LLC (Johnson & Johnson)
• Merz Pharma GmbH & Co. KGaA
• Sientra Inc.
• Polytech Health & Aesthetics GmbH
• Cynosure LLC (Hologic Inc.)
• Cutera Inc.
• Syneron Medical Ltd. (Candela Corporation)
• Alma Lasers Ltd.
• Lumenis Ltd.
• Straumann Group
• Teoxane Laboratories
• Laboratories Vivacy SAS
• Sinclair Pharma plc
• Others

The Europe Cosmetic Surgery Market is segmented as follows:

By Procedure Type

• Surgical Procedures
  • Breast Augmentation
  • Liposuction
  • Rhinoplasty (Nose Job)
  • Abdominoplasty (Tummy Tuck)
  • Facelift
  • Eyelid Surgery (Blepharoplasty)
• Non-Surgical Procedures
  • Botulinum Toxin (Botox)
  • Dermal Fillers
  • Chemical Peels
  • Laser Hair Removal
  • Microdermabrasion

By Gender

• Male
• Female

By End-User

• Ambulatory Surgical Facility
• Hospital and Clinic
• Cosmetic Surgical Center
• Others

Regional Coverage:

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe